Clinical trial Recruiting at 11 sites Observational

Southeast Asian Brugada Syndrome Group

Official title: Discovering the Genetic Causes of Brugada Syndrome in Thais and Southeast Asian Population

Run by Chulalongkorn University · NCT04232787 · Data updated 2026-11-12

A group of Brugada syndrome patients in Thailand are being studied to see how genetic differences relate to their diagnosis and how severe their symptoms are.

Quick facts

Study typeObservational
SexAll
Enrollment750 (estimated)
SponsorChulalongkorn University
Academic / other
Locations11 sites (Bangkok, Bangkok and 10 other locations)
StatusRecruiting
StartedJanuary 28, 2016
Main results expectedJanuary 5, 2031
Study endsJanuary 5, 2031
Registry record updatedOctober 30, 2026
Trial IDNCT04232787 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Thai individuals with confirmed Brugada type 1 ECG (on resting ECG or after provocative testing) who do not have other major cardiac diseases.

Probably not a fit

Individuals without Brugada type 1 ECG criteria or those with significant concurrent cardiac conditions may be less likely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort in Thailand collects demographic, clinical, ECG, and genetic data from Brugada syndrome patients and healthy controls. Researchers perform whole genome sequencing and SNP arrays to identify genetic variants, and then compare findings between cases and controls. Patients are followed over time to monitor symptoms and implantable cardioverter-defibrillator shocks, with analyses linking genetic variants to clinical severity. The study aims to clarify how genetics may influence BrS presentation and prognosis in Southeast Asian populations.

Why it matters

Potential benefit: Greater understanding of genetic factors could improve risk stratification and personalized management for Brugada syndrome patients.

How similar studies have gone: Previous research has linked genetic variation to BrS features, but this Southeast Asian cohort provides novel regional data that may strengthen or refine those associations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Thai nationality
* The patient has at least one of confirmed Brugada type 1 ECG in at least one of right precordial leads (v1 or v2) with or without pharmacologic provocative testing. The confirmed ECG is standard 12 lead ECG or Brugada lead

Exclusion Criteria:

* The patient has other cardiac diseases such as ischemic heart disease, valvular heart disease, congenital heart disease, myocarditis and pericarditis
* The patient has type 2 or type 3 Brugada ECG without type 1 ECG during pharmacologic provocative testing and/or Brugada lead
* The patient had one time of Brugada type 1 ECG during drug use without reproducibility

Where it's running

  • Bangkok Hospital
    Bangkok, Bangkok, Thailand
    Recruiting
  • Siriraj Hospital, Mahidol University
    Bangkok Noi, Bangkok, Thailand
    Recruiting
  • Vajira Hospital
    Dusit, Bangkok, Thailand
    Recruiting
  • Chulalongkorn University
    Pathum Wan, Bangkok, Thailand
    Recruiting
  • Faculty of Medicine Ramathibodi Hospital, Mahidol University
    Ratchathewi, Bangkok, Thailand
    Recruiting
  • Bhumibol Adulyadej RTAF Hospital
    Sai Mai, Bangkok, Thailand
    Recruiting
Show 5 more locations
  • Bumrungrad International Hospital
    Vadhana, Bangkok, Thailand
    Recruiting
  • Pacific Rim Electrophysiology Research Institute Data Coordinating Center
    Vadhana, Bangkok, Thailand
    Recruiting
  • Queen Sirikit Heart Center of the Northeast
    Khon Kaen, Changwat Khon Kaen, Thailand
    Recruiting
  • Central Chest Hospital
    Nonthaburi, Changwat Nonthaburi, Thailand
    Recruiting
  • Faculty of Medicine, Chiang Mai University
    Chiang Mai, Chiang Mai, Thailand
    Recruiting

Study contacts

  • Principal investigator: Apichai Khongphatthanayothin, MD — Chulalongkorn University
  • Study coordinator: Apichai Khongphatthanayothin, MD
  • Email: apichaik@yahoo.com
  • Phone: 66891555545

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.